Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 601 to 625
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 15 meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 295 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 294 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 3 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 13 meeting statement
-
PublicationsFind out when software is classified as an in vitro medical device and how it is regulated.
-
Meeting statementsTherapeutic Goods Committee, 27 August 2013, meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 293 meeting statement
-
Meeting reports and recommendationsThe Australian Therapeutic Goods Advisory Council met for the third time on 6 August 2013
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 14 meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 292 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 291 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 2 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 290 meeting statement
-
Meeting statementsThe TGA asked the ACMD to consider acceptable levels of sensitivity and specificity for Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) PoCTs
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 12 meeting statement
-
Meeting statementsAdvisory Committee on Non-prescription Medicines, 7 March 2013, meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 13 meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 289 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, the joint ACCS and ACMS and ACMS
-
Meeting reports and recommendationsAustralian Therapeutic Goods Advisory Council met for the second time on 5 February 2013
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 288 meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 12 meeting statement